miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity - Wikidata - wikimedia - TriplyDB

miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity

miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity

http://www.wikidata.org/entity/Q38323834

about

Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers Hemostatic disorders of the menopausal period: the role of microRNA The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs Bile acid signaling in metabolic disease and drug therapy miR-29b represses intestinal mucosal growth by inhibiting translation of cyclin-dependent kinase 2 Integrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity.MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatment Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR Perilipin-5 is regulated by statins and controls triglyceride contents in the hepatocyte.Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33 Impaired liver regeneration in Ldlr-/- mice is associated with an altered hepatic profile of cytokines, growth factors, and lipids.MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.Non-coding RNAs and lipid metabolism microRNAs and HDL life cycle.MicroRNAs and lipoproteins: a connection beyond atherosclerosis?Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice miR-183 inhibits invasion of gastric cancer by targeting Ezrin.Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins.Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506.Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players.Modulation by miR-29b of intestinal epithelium homoeostasis through the repression of menin translation.MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis MicroRNA control of high-density lipoprotein metabolism and function Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.Therapeutic Inhibition of miR-33 Promotes Fatty Acid Oxidation but Does Not Ameliorate Metabolic Dysfunction in Diet-Induced Obesity.Function and clinical potential of microRNAs in hepatocellular carcinoma.MicroRNA Regulation of Atherosclerosis.A big role for small RNAs in HDL homeostasis.miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis.MicroRNAs as biomarkers of hepatotoxicity in a randomized placebo-controlled study of simvastatin and ubiquinol supplementation.Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice.MicroRNAs in metabolic disease.MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.Therapeutic silencing of fat-specific protein 27 improves glycemic control in mouse models of obesity and insulin resistance.MicroRNAs and Cardiovascular Disease.Micro-RNAs and High-Density Lipoprotein Metabolism.How Gene Networks Can Uncover Novel CVD Players.microRNAs in lipoprotein metabolism and cardiometabolic disorders.

P2860

Q26746000-8508261C-B8A2-4576-8704-C63D867EB4AD Q26795566-8F38A724-D6BD-4A57-90C4-32C050E068F5 Q26801471-DC67D834-15EF-49F4-B349-1DA3D0C086E4 Q26822987-8B054870-7C51-432C-A0AA-540425226140 Q28244875-FE4355A4-AC78-4943-B549-8BECC1271B1B Q28505972-354E9FE1-DD8D-48D2-923E-ECAE45A7D65E Q30586189-5E62E40D-AC68-4E7F-ACF2-2E31837ECB8C Q33607587-8CAC1C80-A658-4D47-A0CA-4E8C9D9299C9 Q33661920-6600C2D9-7546-4838-8EC1-B8FE08262063 Q33923114-5062FD44-B4FA-4E50-B462-965956BEA9AB Q33940346-3C9D475F-EDC8-4472-AB04-37A34BCCC86B Q34093088-0FA5F12F-C207-4D3C-B4A3-E3DBBD817D8B Q34093118-80C9AA4F-5084-4E40-B110-2E7F14F7208B Q34158382-9FB0E55E-4321-4BA5-97B7-A4F88DD184F2 Q34248289-0F24D73D-077A-4B22-A576-3A336EB75783 Q34321706-13A23FE3-B3A0-43D7-98B3-F6BCD54A02DA Q34342477-2C12A22D-F67A-4E03-8F76-AE96B83E5DD5 Q34371214-57FD648C-A701-4EE3-98B5-84900F0BBBB0 Q34680467-5F52E4CA-BBE6-495E-A2EA-7400CDB9A656 Q34801354-C8734B7D-E6E6-48E0-AF57-BBDC58EE91D7 Q34821020-5D153317-D859-48E7-B59D-C18340C16EF2 Q34860544-EFD3C405-C981-4D76-BF47-E81BC6DF9C5C Q35008059-353BC1A0-783E-40A3-A138-51678C4A504B Q35200081-1764A575-BCBB-4AA1-8076-920D69F33195 Q36083076-0FFE17C6-D8CD-4B4D-A48E-FCA0613CB35A Q36326825-B8C7AA76-CFE5-49F9-A6D8-22992E3BE6E6 Q36336198-5575AF2E-D7EF-4CD9-B0F8-4C8566786640 Q36602813-C15A8B89-32E0-4755-99A3-1503511F9878 Q36754770-AD6AF56F-DF3C-4083-8447-FA05967B8707 Q36849588-F1CA6150-DB87-4280-98EC-954C81E85F78 Q36912465-EAAD2752-4EAA-4DE5-A87E-224D6AF0F1B9 Q37071691-2977FA52-91CE-4FF6-9459-421522298705 Q37075782-E20FB1DC-928F-49A6-B5C7-DFDE4041D6A6 Q37088373-FFEE08D2-E903-4385-8E17-B345095820EE Q37394060-210E73EB-567B-47C6-9484-97491CD7BEFE Q37585546-D5495262-B989-42F7-A0E6-AFE8B5D72E74 Q37593859-77E176F2-E7B8-4CD9-B8F8-C07270068A21 Q37650114-7B825309-547A-4F42-80F8-4666BFCBB0E7 Q37664007-33150E4F-55F2-48AA-A87D-58F29D0F0410 Q37709886-4484F033-7B63-4857-9CEE-DA4658D6C22B

P2860

miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity

http://www.wikidata.org/entity/Q38323834

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

miR-33 controls the expression ...... nd diet-induced hepatotoxicity

@en

type

label

miR-33 controls the expression ...... nd diet-induced hepatotoxicity

@en

prefLabel

miR-33 controls the expression ...... nd diet-induced hepatotoxicity

@en

P1433

Q38323834-5C9FEEA6-3431-469C-AC5D-7B27E93B87FA

P1476

Q38323834-EEDA6427-678D-459F-B6B2-74E19A232B58

P2093

Q38323834-2D04EB71-05BC-4288-BC95-755B5E39440C

Q38323834-38A02D26-3EB0-436B-ACAA-048A5E7D654B

Q38323834-44BF786C-5BE9-47F3-9A28-77250B1BA1CA

Q38323834-76D4C4A5-2DDD-4EC6-84DD-0F64B7949B1F

Q38323834-9307A735-DFFA-4B4D-A5D8-775F7FB346C3

Q38323834-C910207E-66B0-41A9-A97D-BAA59F09682C

Q38323834-CBC96312-6CD2-44F9-8DE4-AAD4010B31B1

P2860

Q38323834-028281D4-6B69-4EAE-A83F-1C835B0E45E2

Q38323834-0983F9C1-61E0-4F83-9712-50E0EA23BB52

Q38323834-0A7CBB31-1A37-4087-95C5-6B76C4E20E92

Q38323834-0E7DAB45-B096-432F-A238-65E2AC51BD5F

Q38323834-0E947984-5E18-460C-B74B-2976580D4CDC

Q38323834-155A0F68-D755-44A4-9D73-045755032B42

Q38323834-1B32EBEC-09D8-432E-9E0F-B8B1BEC1007C

Q38323834-1D2628C2-D7E1-4156-BAD5-2AD261E7F0DA

Q38323834-246A4E66-323A-4CF1-B9F5-69AE5D07A694

Q38323834-3048C04C-E1F4-4A39-9741-6B36AF45B18D

P304

Q38323834-A6E147E3-55D2-4336-94FE-D627791AC000

P31

Q38323834-04D322A4-7B77-4744-8235-1B9A3D7B793E

P356

Q38323834-EA2418D1-C836-4F42-BDE2-E3DD236DEFAA

P433

Q38323834-07AC498D-9C20-45B3-B66F-CBCE3598643A

P478

Q38323834-069B0C49-A086-4C32-B68D-6652FB9B35DE

P50

Q38323834-D3109752-A5BB-4D66-9C5E-E778815A9283

P577

Q38323834-D6A9AB03-EE31-4F3C-998D-FC4E56837113

P5875

Q38323834-427F1D3A-44E8-4E96-AE72-8DDB26A195BA

P698

Q38323834-7F267053-C7AB-4091-BBCE-6F7619167C95

P921

Q38323834-43F1153F-F33A-4194-99D7-115006536E42

Q38323834-8F6D04AD-F0BA-4C7D-AF8C-E401B186807F

Q38323834-E5264E51-F1BE-4601-8839-55567C0B115C

Q38323834-F20DA5F9-8A19-4AD7-AE02-DBFEDF29F957

P932

Q38323834-0B5D8F5C-4B6C-4AD4-AF1C-1EDFDA8637B2

P356

P1433

EMBO Molecular Medicine

P1476

miR-33 controls the expression ...... nd diet-induced hepatotoxicity

@en

P2093

Angel Baldán

http://www.w3.org/2001/XMLSchema#string

Carolyn J Albert

http://www.w3.org/2001/XMLSchema#string

David Q-H Wang

http://www.w3.org/2001/XMLSchema#string

Frederick J Suchy

http://www.w3.org/2001/XMLSchema#string

Meenakshisundaram Ananthanarayanan

http://www.w3.org/2001/XMLSchema#string

Ryan M Allen

http://www.w3.org/2001/XMLSchema#string

Tyler J Marquart

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1

Scavenger receptor BI-mediated selective uptake is required for the remodeling of high density lipoprotein by endothelial lipase

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia

Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity

Progressive familial intrahepatic cholestasis: genetic disorders of biliary transporters

Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples

Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion

P304

882-895

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201201228

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228331228

http://www.w3.org/2001/XMLSchema#string

P698

22767443

http://www.w3.org/2001/XMLSchema#string

P921

regulation of bile acid secretion

positive regulation of bile acid secretion

negative regulation of bile acid secretion

P932

3491822

http://www.w3.org/2001/XMLSchema#string